Spero Therapeutics Inc. (SPRO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Spero Therapeutics Inc.

    NASDAQ: SPRO · Real-Time Price · USD
    2.15
    0.01 (0.47%)
    At close: Sep 05, 2025, 3:59 PM
    2.15
    0.00%
    After-hours: Sep 05, 2025, 05:13 PM EDT

    Spero Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 27.4M 96.73M 48.58M 18.26M
    Cost of Revenue
    		 2K 367K 1.55M 1.12M
    Gross Profit
    		 27.39M 96.37M 5.92M 17.14M
    Operating Income
    		 -73.36M 21.48M -42.2M -87.97M
    Interest Income
    		 4.74M 3.94M 1.11M 346K
    Pretax Income
    		 -68.57M 25.4M -46.41M -89.76M
    Net Income
    		 -68.57M 22.81M -46.41M -89.76M
    Selling & General & Admin
    		 23.7M 25.55M 36.48M 41.7M
    Research & Development
    		 96.76M 51.44M 47.59M 64.53M
    Other Expenses
    		 -19.7M -1.74M -35.96M -15.19M
    Operating Expenses
    		 100.76M 75.25M 48.11M 91.04M
    Interest Expense
    		 n/a n/a 2.6M 1.94M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 100.76M 75.25M 84.08M 106.23M
    Income Tax Expense
    		 n/a 2.6M 1.61M 1.54M
    Shares Outstanding (Basic)
    		 54.04M 52.7M 37.59M 30.9M
    Shares Outstanding (Diluted)
    		 54.04M 52.99M 37.59M 30.9M
    EPS (Basic)
    		 -1.27 0.43 -1.23 -2.91
    EPS (Diluted)
    		 -1.27 0.43 -1.23 -2.91
    EBITDA
    		 -72.48M 25.77M -42.26M -87.17M
    EBIT
    		 -72.48M 25.4M -43.81M -87.82M
    Depreciation & Amortization
    		 2K 367K 1.55M 646K

    Add to Watchlist